Tricyclic Antidepressants May Reduce Cirrhosis Risk in Hepatitis C - Infectious Disease Advisor

Infectious Disease AdvisorTricyclic Antidepressants May Reduce Cirrhosis Risk in Hepatitis CInfectious Disease AdvisorPatients with hepatitis C who take tricyclic antidepressants (TCAs) have decreased fibrosis progression and a lower risk of developing cirrhosis, according to results published in the Journal of Viral Hepatology. These results indicate a potential new ...and more »